Relmada Therapeutics Inc (STU:4E2)
€ 3.88 -0.040 (-1.02%) Market Cap: 418.23 Mil Enterprise Value: 231.84 Mil PE Ratio: 0 PB Ratio: 2.37 GF Score: 29/100

Relmada Therapeutics Inc (STU:4E2) Transcripts

  • 1